Differentiated thyroid cancer : Are we overtreating

Created using ChatSlide

In my keynote, "DTC: Are We Overtreating?" I will explore the current landscape of differentiated thyroid cancer management from a healthcare perspective. We'll analyze whether treatment approaches are excessively aggressive, guided by recent epidemiology trends and patient outcomes. Emphasis will be placed on optimizing treatment strategies through evidence-based guidelines developed using systematic reviews and stakeholder inputs. Attendees will gain insights into balancing treatment...